8-K
Current Report
Keros Therapeutics, Inc. Filed Acc 0001664710-22-000027
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading kros-20220601.htm…